Skip to content

   Pharma Publications

Neuropsychopharmacology
  • ACNP 64th Annual Meeting: Panels, Mini-Panels and Study Groups
    Published on 2025-12-17
    9 months ago
  • Cue labeling reduces cigarette craving and associated neural activity
    Published on 2025-12-16
    9 months ago
  • Re-engineering the disordered mind: clinical experimentation, dynamical systems, and AI for personalized psychiatry
    Published on 2025-12-16
    9 months ago
  • Females have shorter scalp-to-cortex distances and receive stronger TMS electrical fields: Implications for clinical treatment
    Published on 2025-12-15
    9 months ago
  • When the science alone is not enough: embracing our responsibility as science communicators
    Published on 2025-12-15
    9 months ago
  • Amygdala reactivity to threat, negative facial perception, and risk of future psychiatric hospitalizations: a longitudinal study in major depressive and bipolar disorders
    Published on 2025-12-14
    9 months ago
  • An adolescent hangover: astrocyte dysfunction in paraventricular thalamus promotes adult anxiety after alcohol exposure in adolescent mice
    Published on 2025-12-12
    9 months ago
« Previous 1 … 37 38 39 40 41 … 143 Next »
Journal of Psychopharmacology
  • Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression
    Published on 2025-03-25
    1 year ago
  • Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model
    Published on 2025-03-25
    1 year ago
  • Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
    Published on 2025-03-18
    1 year ago
  • A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report
    Published on 2025-03-13
    2 years ago
  • Lifetime classic psychedelic use and headaches: A cross-sectional study
    Published on 2025-03-12
    2 years ago
  • A three-stage strategy for conducting an experimental investigation: A recommendation to improve the reproducibility of reported conclusions
    Published on 2025-03-12
    2 years ago
  • Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study
    Published on 2025-02-28
    2 years ago
« Previous 1 … 37 38 39 40 41 … 154 Next »
European Neuropsychopharmacology
  • Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: A systematic review and meta-analysis
    Published on 2024-11-29
    2 years ago
  • Clinical sleep staging for insomnia disorder
    Published on 2024-11-29
    2 years ago
  • Cannabis use and psychosis: evidence and new clinical features of a new epidemic
    Published on 2024-11-29
    2 years ago
  • Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality
    Published on 2024-11-29
    2 years ago
  • Association between genetic risk of attention deficit hyperactivity disorder and trajectories of daily gaming time in children
    Published on 2024-11-29
    2 years ago
  • Corrigendum to “Lung function decline in people with serious mental illness: A call to action” [European Neuropsychopharmacology (2024) 41-46/ ENP-24-342]
    Published on 2024-11-22
    2 years ago
  • The need for specific mental health interventions for the prevention of suicide in postpandemic times
    Published on 2024-11-15
    2 years ago
« Previous 1 … 37 38 39 40 41 … 170 Next »

   Pharma Pub